The size of the Latin America hair loss treatment products market is expected to be worth USD 0.2 bn by 2029 from USD 0.16 bn in 2024, growing at a CAGR of 5.08% from 2024 to 2029.
The increasing trend towards hair loss treatment procedures, especially among women, is a major factor for growth in the Latin America Hair Loss Treatment Products market. Increasing expenditure on hair care products is also propelling the Latin America Hair Loss Treatment Products Market's growth rate. One of the major driving factors that help the growth of the Latin America Hair Loss Treatment Products Market is rising approvals from the government organization and raising awareness of the availability of new procedures promotes the growth of the market in the Latin America region.
Another major driving factor of Latin America Hair Loss Treatments Products is the key players' increase of investments that help the market grow further. Also, the rising prevalence of beauty consciousness is escalating the demand of the market in this area.
However, the high cost of the treatment procedures hinders the growth rate of the Latin America Hair Loss Treatment Products Market. The lack of professionals in performing effective treatment procedures, especially in undeveloped countries, is restraining the market's demand.
Impact of COVID-19 on Latin America hair loss treatment products market:
The business was affected mainly in 3 ways due to the pandemic, such as directly affecting production, creating supply chain and market disturbance, and financially. This Coronavirus pandemic has impacted financially in every sector like restaurants, manufacturing units, flights, traveling, and so many sectors to halt their services. Due to COVID-19, the Latin America Hair Loss Treatment Products Market is also facing difficulties and witnessed huge financial losses due to the financial crisis they had faced. As per the report, the market for hair loss treatment products is expected to increase much further owing to increasing expenditure on hair care products, which will propel the revenue shares of the market in the following years. The increasing need for hair among men is also likely to promote the call for hair loss treatment products in the projection period.
REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
CAGR |
4.1% |
Segments Covered |
Based on Disease Type, End-User, Sales Channel and Country |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
Brazil, Mexico, Argentina, Colombia and Rest of Latin America |
Market Leaders Profiled |
Concert Pharmaceuticals, Merck & Co., Inc., Aclaris Therapeutics, Inc., Hcell Inc., Histogen Inc., Sun Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc., and Glaxo Smith Kline Plc. |
This research report on the Latin American hair loss treatment products market has been segmented and sub-segmented on the following categories.
Latin America Hair Loss Treatment Products Market - By Type of Disease:
Latin America Hair Loss Treatment Products Market - By End-User:
Latin America Hair Loss Treatment Products Market - By Sales Channel:
Latin America Hair Loss Treatment Products Market - By Country:
Latin America region is expected to increase the market share of hair loss treatment products. Changes in lifestyle and increasing stress levels are major causes of hair loss, which are also some factors to boost the demand in the Latin America Hair Loss Treatment Products Market. The increasing prevalence of aesthetic appearance is likely to fuel the demand of the market in this region. Along with this, increasing investments in the development of new devices with the latest technologies are enhancing the growth rate of the market.
KEY MARKET PLAYERS:
Some of the key players in the Latin America hair loss treatment products market include Concert Pharmaceuticals, Merck & Co., Inc., Aclaris Therapeutics, Inc., Hcell Inc., Histogen Inc, Sun Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc., and Glaxo Smith Kline Plc.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region